Clinical Trial Update: Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for Transcranial Electromagnetic Treatment (TEMT) targeting Alzheimer's disease across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Transcranial Electromagnetic Treatment (TEMT)

Snippet

Sponsor: NeuroEM Therapeutics, Inc. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: UNKNOWN